Synbio® – a two-strain probiotic for fatigue, digestive comfort, and more We recently added a new building block, Synbio®, consisting of two probiotic strains, L. rhamnosus IMC501 and L. paracasei IMC502. Fatigue reduction One of the most intriguing...
The metabolome: Adding a new layer of precision to treatment selection Last year, our partner Biovis introduced metabolome analysis. It measures metabolites that are produced by microbes in the gut, which means that it moves the analysis from “who is there?” to “what...
Seeking the best treatment for each patient Every practitioner strives to provide the best treatment for each patient. However, determining what is “the best” treatment can be challenging – particularly in patients with multimorbidity, which is the most common...
The microbiome in QFS and other Post-Acute Infectious Syndromes (PAIS) In shortIn patients with Post-Acute Infectious Syndromes (PAIS), such as Q fever fatigue syndrome (QFS), ME/CFS, and long COVID, consistent gut microbiome dysbiosis is observed. In a pilot project...
Celiac disease is not just genetic Celiac disease is often considered to have a genetic cause. It is a chronic systemic autoimmune disease that is characterized by loss of tolerance to dietary gluten. Although it occurs in genetically predisposed individuals, not...
Introduction of new and unique strain: B. adolescentis SH001 There are several Bifidobacterium species on the market as probiotics, for example B. lactis, B. longum, or B. breve. A less well-known bacterial species of... 
Recent Comments